Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

85.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
85.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome wide association study meta-analysis of neuropathologic lesions of Alzheimer's disease and related dementias in a multi-site autopsy cohort.

PLoS genetics·2026
Same author

Combining post-mortem and neuroimaging measures of brain amyloidosis to accelerate genomic discovery.

Brain : a journal of neurology·2026
Same author

Riboregulation: a non-canonical tau function.

Molecular neurodegeneration·2026
Same author

Traumatic brain injury and late-life Alzheimer's disease neuropathology: Quantitative investigation in the Adult Changes in Thought study.

Journal of Alzheimer's disease : JAD·2026
Same author

Neuropathological study of the effects of aducanumab anti-Aβ immunotherapy on patients with Alzheimer's disease.

Acta neuropathologica·2026
Same author

Somatic mutations reveal the ontogeny of human microglia.

bioRxiv : the preprint server for biology·2026
Same journal

Tetrahedral DNA nanostructure-delivered suppressor tRNA ameliorates nephropathy in <i>COL4A5</i> nonsense mutation-mediated Alport syndrome mice.

NAR molecular medicine·2026
Same journal

A yeast recombination system recapitulates the length polymorphism of a microsatellite implicated in human social behavior.

NAR molecular medicine·2026
Same journal

Genetic or pharmacological disruption of the MSH3 Y245/K246 IDL binding pocket slows CAG repeat expansion.

NAR molecular medicine·2026
Same journal

MCVAE-based multi-omic anomaly detection in Fragile X Syndrome.

NAR molecular medicine·2026
Same journal

Aptamer-mediated modulation of PAI-1 function reveals a novel mechanism for restoring fibrinolytic balance.

NAR molecular medicine·2026
Same journal

Evolutionary refinement of the ZIKV 5' UTR dictates a trade-off between RNA stability and promoter accessibility.

NAR molecular medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.9K

Tri-snRNP activity modulates tauopathy phenotypes.

Katherine R LeBlanc1,2, Randall J Eck1,3, Aleen D Saxton4

  • 1Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle 98104 WA, United States.

NAR Molecular Medicine
|November 19, 2025
PubMed
Summary
This summary is machine-generated.

A mutation in the dib-1 gene protects against Alzheimer's disease (AD) and other tauopathies by improving RNA splicing. This finding suggests targeting spliceosomes could treat neurodegenerative diseases.

More Related Videos

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
09:12

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

6.7K
Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases
10:38

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases

Published on: December 22, 2023

1000

Related Experiment Videos

Last Updated: Jan 11, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.9K
Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
09:12

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

6.7K
Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases
10:38

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases

Published on: December 22, 2023

1000

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Alzheimer's disease (AD) and tauopathies are neurodegenerative disorders impacting cognition and memory.
  • Pathogenic tau accumulation in the brain is a hallmark of these conditions.
  • Caenorhabditis elegans models recapitulate key aspects of human tauopathy, including neurodegeneration.

Purpose of the Study:

  • To identify genetic factors that modulate tau pathology using forward genetic screens in a C. elegans model.
  • To investigate the role of the dib-1 gene and its human homolog TXNL4A in tauopathy.
  • To explore the link between RNA splicing and neurodegeneration in tauopathies.

Main Methods:

  • Forward genetic screens in C. elegans to identify mutations affecting tau pathology.
  • Characterization of the dib-1 mutation's effects on tau-driven phenotypes, neurodegeneration, and tau levels.
  • RNA sequencing to analyze gene expression and splicing patterns in dib-1 mutants.
  • Investigation of nonsense-mediated decay pathways in conjunction with the dib-1 mutation.

Main Results:

  • A single point mutation in dib-1 significantly ameliorated tau-driven behavioral defects, prevented neurodegeneration, and reduced tau protein levels.
  • dib-1 encodes TXNL4A, a component of the spliceosome's tri-snRNP complex.
  • RNA sequencing revealed widespread intron retention in dib-1 mutants, indicating disrupted splicing.
  • Loss of function in prp-8, another tri-snRNP component, also protected against tauopathy.
  • TXNL4A levels were found to be decreased in human AD frontal cortex samples.

Conclusions:

  • Pathological tau accumulation appears to impair spliceosomal function.
  • Modulating spliceosomal activity, as demonstrated by the dib-1 mutation, can ameliorate tauopathy.
  • The dib-1/TXNL4A pathway represents a potential therapeutic target for Alzheimer's disease and other tauopathies.